58 related articles for article (PubMed ID: 1360142)
1. [Immunohistochemical study of cell proliferation in breast cancer: preliminary report].
Horiguchi J; Iino Y; Takei H; Yokoe T; Ishikita T; Ishida T; Morishita Y
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1454. PubMed ID: 1360142
[No Abstract] [Full Text] [Related]
2. [Expression of proliferating cell nuclear antigen (PCNA) in breast cancer: preliminary report].
Kanemoto H; Okajima K; Ryo T; Osada K; Ichinoma T; Miyoshi K; Iwamoto S
Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):477. PubMed ID: 7915399
[No Abstract] [Full Text] [Related]
3. [The evaluation of proliferating activity in gastric carcinoma stained by proliferating cell nuclear antigen (PCNA): preliminary report].
Nakano H; Namatame K; Suzuki T; Nakayoshi A; Kumada K
Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):216. PubMed ID: 1348104
[No Abstract] [Full Text] [Related]
4. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.
Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R
J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of p105 expression and malignancy in gastric cancers].
Yonemura Y; Oyama S; Kimura H; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):118-21. PubMed ID: 1674814
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer.
Jensen V; Ladekarl M; Holm-Nielsen P; Melsen F; Soerensen FB
J Pathol; 1995 Aug; 176(4):343-52. PubMed ID: 7562249
[TBL] [Abstract][Full Text] [Related]
12. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
Frierson HF
Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
[TBL] [Abstract][Full Text] [Related]
14. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of the proliferation of breast cancer cells based on the expression of proliferating cell nuclear antigen (PCNA)].
Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(1):49-53. PubMed ID: 9578731
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.
Aaltomaa S; Lipponen P; Syrjänen K
Anticancer Res; 1993; 13(2):533-8. PubMed ID: 8100128
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
18. [Expression of proliferating cell nuclear antigen (PCNA) and its correlation with Ki-67, TfR, ET, PgR, pTNM in carcinoma of the breast].
Rizzo A; Crisafulli C; Maiorca A; Tuccari G
Pathologica; 1992; 84(1094):65-9. PubMed ID: 1363759
[No Abstract] [Full Text] [Related]
19. Immunohistochemical study of craniopharyngiomas.
Kubo O; Tajika Y; Uchimuno H; Muragaki Y; Shimoda M; Hiyama H; Morishita K; Takakura K
Noshuyo Byori; 1993; 10(2):131-4. PubMed ID: 7693229
[TBL] [Abstract][Full Text] [Related]
20. Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA).
Start RD; Cross SS; Clelland C; Silcocks PB; Rogers K; Smith JH
J Pathol; 1992 Oct; 168(2):197-9. PubMed ID: 1361001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
